APTAMERS ARE NEW PHARMACOLOGICAL SUBSTANCES FOR THE DEVELOPMENT OF ANTICOAGULANTS
A ptamers are a new class of oligonucleotide compounds capable of specific binding to various molecular targets and inhibiting their activity. Aptamers are selected from a library of randomly syn-thesized oligonucleotides (from 20 to 60 nucleotides long) based on their ability to bind to the target...
Main Authors: | A. V. Mazurov, V. A. Spiridonova |
---|---|
Format: | Article |
Language: | Russian |
Published: |
«REMEDIUM GROUP» Ltd.
2017-05-01
|
Series: | Атеротромбоз |
Subjects: | |
Online Access: | https://www.aterotromboz.ru/jour/article/view/116 |
Similar Items
-
Aptamers Regulating the Hemostasis System
by: Anatoly A. Vaganov, et al.
Published: (2022-12-01) -
Aptamer-based applications for cardiovascular disease
by: Xinyuan Chen, et al.
Published: (2022-10-01) -
Thermodynamic, Anticoagulant, and Antiproliferative Properties of Thrombin Binding Aptamer Containing Novel UNA Derivative
by: Weronika Kotkowiak, et al.
Published: (2018-03-01) -
Sticky and promiscuous plasma proteins maintain the equilibrium between bleeding and thrombosis
by: Swiss Medical Weekly
Published: (2002-04-01) -
Design of Potent and Controllable Anticoagulants Using DNA Aptamers and Nanostructures
by: Abhijit Rangnekar, et al.
Published: (2016-02-01)